Evidence map›Paper›PMID 41286706›Full record

ArticleBMC public health2025

Sustainable development goal 3: is Ghana on track with neonatal mortality?

Zakariya Kuupah Adama, Sabina Abuga, Solomon Opoku, Joel Welbeck

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zakariya Kuupah AdamaUniversity of Ghana, Accra, Ghana. adamazakariya39@gmail.com.
Sabina AbugaUniversity of Cape Coast, Cape Coast, Ghana.
Solomon OpokuUniversity of Cape Coast, Cape Coast, Ghana.
Joel WelbeckUniversity of Cape Coast, Cape Coast, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite progress in child health, deaths occurring in the neonatal period remain a major contributor to under-five mortality in Ghana, posing a significant public health challenge. SDG 3.2 aims to reduce neonatal mortality to at least as low as 12 deaths per 1,000 live births by 2030. This study investigates the trends and progress of neonatal mortality rates in Ghana from 1960 to 2022, with an emphasis on assessing the country's advancement toward achieving Sustainable Development Goal (SDG) 3.2. Data were obtained from the World Development Indicators (WDI) and processed using Microsoft Excel and analyzed using R statistical software. The AutoRegressive Integrated Moving Average (ARIMA) time series model was employed as the statistical model for this study. The results show a consistent decline in neonatal mortality over the study period. In 2023, the rate was estimated at 20.59 deaths per 1,000 live births, and it is projected to decline further to 17.60 deaths per 1,000 live births by 2030. While this downward trend is encouraging, the 95% confidence intervals show considerable uncertainty: the 2030 upper bound remains well above the SDG 3.2 target, while the lower bound is only marginally above it. This indicates that Ghana may come close to the goal under favorable conditions, but is not assured of meeting it unless the rate of progress is significantly accelerated. These findings offer critical insights for policymakers and stakeholders, emphasizing the need for intensified efforts and strategic health interventions to achieve meaningful reductions in neonatal mortality by 2030.

Indexed as

Infant MortalitySustainable DevelopmentFemaleGhanaGoalsHumansInfantInfant, NewbornARIMA modelGhanaNeonatal mortalityPublic healthSustainable Development Goals (SDG)

Identifiers

PMID41286706
PMCPMC12642074

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.